Atrial natriuretic peptide (ANP) plays a key regulatory role in arterial blood pressure homeostasis. We recently generated mice with selective deletion of the ANP receptor, guanylyl cyclase-A (GC-A), in vascular smooth muscle (SMC GC-A knockout (KO) mice) and reported that resting arterial blood pressure was completely normal in spite of clear abolition of the direct vasodilating effects of ANP (Holtwick, R., Gotthardt, M., Skryabin, B., Steinmetz, M., Potthast, R., Zetsche, B., Hammer, R. E., Herz, J., and Kuhn M. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 7142-7147). The purpose of this study was to clarify mechanisms compensating for the missing vasodilator responses to ANP. In particular, we analyzed the effect of the endothelial, cGMP-mediated vasodilators C-type natriuretic peptide and nitric oxide (NO). In isolated arteries from SMC GC-A KO mice, the vasorelaxing sensitivity to sodium nitroprusside and the endotheliumdependent vasodilator, acetylcholine, was significantly greater than in control mice. There was no difference in responses to C-type natriuretic peptide or to the activator of cGMP-dependent protein kinase I, 8-para-chlorophenylthio-cGMP. The aortic expression of soluble GC (sGC), but not of endothelial NO synthase or cGMP-dependent protein kinase I, was significantly increased in SMC GC-A KO mice. Chronic oral treatment with the NO synthase inhibitor N w -nitro-L-arginine methyl ester increased arterial blood pressure, the effect being significantly enhanced in SMC GC-A KO mice. We conclude that SMC GC-A KO mice exhibit a higher vasodilating sensitivity to NO. This can be attributed to an enhanced expression of sGC, whereas the expression and/or activity levels of downstream cGMP-effector pathways are not involved. Increased vasodilating responsiveness to endothelial NO contributes to compensate for the missing vasodilating effect of ANP in SMC GC-A KO mice.Cyclic GMP-dependent modulation of vascular tone is fundamental to the regulation of blood pressure. The levels of cGMP in vascular smooth muscle cells (SMC) 1 are regulated by the activities of three different guanylyl cyclases (GCs): soluble GC (sGC), the intracellular receptor for endothelial nitric oxide (NO) (1); particulate GC-A, a specific membrane receptor for the cardiac natriuretic peptides, atrial (ANP) and B-type (BNP) natriuretic peptides (2, 3); and particulate GC-B, a specific receptor for the endothelial C-type natriuretic peptide (CNP) (4, 5). Stimulation of either GC results in the conversion of GTP to the intracellular messenger cGMP. Subsequent increases in cellular cGMP modulate the activity of specific cGMP-effector molecules, i.e. cGMP-dependent protein kinase I (PKG I), ultimately leading to decreased cytosolic calcium levels and relaxation of vascular smooth muscle cells (6, 7). Thereby, local factors released by the vascular endothelium (NO and CNP) and circulating hormones (ANP and BNP) cooperate in the cGMP-mediated regulation of vascular tone. In addition, it has been suggested that the vasodilating effect o...